|
|
Product search for: naphthacened
IUPAC name
CAS
EINECS
Formula
(7R)-8-Ethyl-7,8,9,10-tetrahydro-1,4,6,7,8α,10β,11-heptahydroxy-5,12-naphthacenedione
21204-30-8
(7R)-8-Ethyl-7,8,9,10-tetrahydro-1,4,6,7β,8α,10α,11-heptahydroxy-5,12-naphthacenedione
17514-32-8
5,12-Naphthacenedione,7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-
24385-10-2
C21H18O9
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(1S)-1-hydroxyethyl-1-methoxy-, (8S,10S)-
28008-51-7
5,12-Naphthacenedione,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,(8S,10S)-
20830-81-3
244-069-7
C27H29NO10
5,12-Naphthacenedione, 10-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy-7,8,9,10-tetrahydro-1,8,11-trihydroxy-8-(hydroxyacetyl)-, (8S,10S)-
81382-05-0
5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-ly xo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-8-hydroxy-1,6,11-trimethoxy-, (8s-cis)-
69804-37-1
5,12-Naphthacenedione,9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-,hydrochloride (1:1), (7S,9S)-
57852-57-0
260-990-7
C26H27NO9.HCl
5,12-Naphthacenedione, 8-acetyl-10-3-(acetylamino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
32385-10-7
5,12-Naphthacenedione, 10-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy-7,8,9,10-tetrahydro-8,11-dihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-
71800-89-0
5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-
23214-92-8
245-495-6
C27H29NO11
(7R)-10α-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-ethyl-7,8,9,10-tetrahydro-1,6,7β,8α,11-pentahydroxy-5,12-naphthacenedione
103782-06-5
1,12(4H,5H)-naphthacenedione, 2-acetyl-4-amino-4a,5a,6,12a-tetrahydro-3,6,10,11,12a-pentahydroxy-6,9-dimethyl-, (4s-(4alpha,4aalpha,5aalpha, 6beta,12aalpha))-
81919-29-1
5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-
56420-45-2
C27H29NO11
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopy ranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(2-oxop ropyl)-, (8s-cis)-
79438-97-4
C28H31NO10
5,12-Naphthacenedione, 10-[ (3-amino-2,3, 6-trideoxy-alpha-L-lyxo-he xopyranosyl)oxy]-7,8,9, 10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hy drochloride, (8s-cis)-
75363-85-8
5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,(8S,10S)-
54193-28-1
C27H31NO11
5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-2,3,6-trideoxy-3-(methoxycarbonyl)amino-alpha-L-lyxo-hexopyranosyloxy-, (8s-cis)-
38942-79-9
5,12-Naphthacenedione,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,hydrochloride (1:1), (8S,10S)-
23541-50-6
245-723-4
C27H29NO10.HCl
5,12-Naphthacenedione, 10-(2R,4S,5S,6S)-4-aminotetrahydro-5-iodo-6-methyl-2H-pyran-2-yloxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-
83997-75-5
(7R)-8-Ethyl-7,8,9,10-tetrahydro-1,4,6,8α,11-pentahydroxy-7β,10α-bis[[2,3,6-trideoxy-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
1403-81-2
5,12-Naphthacenedione, 8-acetyl-10-((3-(bis(phenylmethyl)amino)-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8s-cis)-
80951-48-0
5,12-Naphthacenedione, 8-acetyl-10-[[3-(cyclohexylamino)-2,3, 6-trideo xy-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9, 10-tetrahydro-6,8,11-trihy droxy-1-methoxy-, hydrochloride, (8s-cis)-
79898-09-2
(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione (doxorubicin impurity)
106401-68-7
5,12-Naphthacenedione,10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-
72496-41-4
C32H37NO12
(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-á-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide(>85%)(Doxorubic
148218-14-8
C29H35Br2NO11
5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((N-(N,N-dimethylglycyl)glycyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, monohydrochloride, (8s-c
58161-65-2
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(1,2-dihydroxyethyl)-1-me thoxy-10-((2,3,6-trideoxy-3-((phenylmethyl)amino)-alpha-L-lyxo-hexopyr anosyl)oxy)-6,8,11-trihydroxy-, hydrochloride, (8s-cis)-
70844-19-8
(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrobromide(>85%)(doxorubicin imp
148218-14-8
C29H35Br2NO11
|
|
|
How do you find new customers?
click here
|